Hillary Lum
Concepts (351)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Advance Care Planning | 41 | 2023 | 197 | 15.140 |
Why?
| Palliative Care | 16 | 2023 | 644 | 3.400 |
Why?
| Patient Portals | 5 | 2020 | 33 | 2.220 |
Why?
| Patient Participation | 5 | 2020 | 358 | 2.060 |
Why?
| Hospice Care | 5 | 2023 | 185 | 1.920 |
Why?
| Terminal Care | 6 | 2023 | 213 | 1.900 |
Why?
| Physicians | 8 | 2023 | 772 | 1.810 |
Why?
| Primary Health Care | 11 | 2023 | 1514 | 1.720 |
Why?
| Dementia | 4 | 2023 | 187 | 1.690 |
Why?
| Suicide, Assisted | 5 | 2023 | 20 | 1.620 |
Why?
| Communication | 13 | 2023 | 744 | 1.600 |
Why?
| Aged | 50 | 2025 | 19075 | 1.590 |
Why?
| Advance Directives | 8 | 2021 | 69 | 1.490 |
Why?
| Electronic Health Records | 6 | 2020 | 800 | 1.460 |
Why?
| Parkinson Disease | 3 | 2020 | 345 | 1.460 |
Why?
| Physician-Patient Relations | 7 | 2019 | 462 | 1.380 |
Why?
| Documentation | 4 | 2020 | 167 | 1.340 |
Why?
| Caregivers | 9 | 2023 | 717 | 1.330 |
Why?
| Pandemics | 7 | 2022 | 1320 | 1.320 |
Why?
| Skilled Nursing Facilities | 5 | 2022 | 121 | 1.280 |
Why?
| Volunteers | 2 | 2019 | 31 | 1.250 |
Why?
| Quality Improvement | 6 | 2023 | 950 | 1.210 |
Why?
| Heart Failure | 7 | 2023 | 1945 | 1.210 |
Why?
| Hospices | 2 | 2022 | 83 | 1.200 |
Why?
| Humans | 102 | 2025 | 114711 | 1.180 |
Why?
| Cognitive Dysfunction | 2 | 2022 | 284 | 1.160 |
Why?
| Surveys and Questionnaires | 18 | 2023 | 4624 | 1.130 |
Why?
| Home Care Services | 5 | 2023 | 223 | 1.030 |
Why?
| Subacute Care | 4 | 2021 | 71 | 1.020 |
Why?
| Aged, 80 and over | 19 | 2025 | 6346 | 1.010 |
Why?
| Qualitative Research | 11 | 2023 | 936 | 0.940 |
Why?
| Home Health Aides | 1 | 2023 | 5 | 0.890 |
Why?
| Medical Marijuana | 3 | 2020 | 97 | 0.880 |
Why?
| Hospice and Palliative Care Nursing | 2 | 2023 | 69 | 0.860 |
Why?
| Life Support Care | 2 | 2020 | 28 | 0.840 |
Why?
| Health Knowledge, Attitudes, Practice | 5 | 2020 | 1183 | 0.830 |
Why?
| Group Processes | 2 | 2020 | 53 | 0.820 |
Why?
| Health Services for the Aged | 2 | 2020 | 70 | 0.810 |
Why?
| Male | 43 | 2025 | 55669 | 0.780 |
Why?
| Patient Care Team | 3 | 2021 | 517 | 0.770 |
Why?
| Female | 48 | 2025 | 59573 | 0.770 |
Why?
| Practice Patterns, Physicians' | 3 | 2019 | 1177 | 0.760 |
Why?
| Huntington Disease | 1 | 2021 | 40 | 0.740 |
Why?
| Housing | 1 | 2022 | 114 | 0.730 |
Why?
| Living Wills | 1 | 2020 | 8 | 0.730 |
Why?
| Patient-Centered Care | 3 | 2021 | 473 | 0.720 |
Why?
| Music Therapy | 1 | 2020 | 21 | 0.710 |
Why?
| Medicare | 4 | 2023 | 665 | 0.700 |
Why?
| Music | 1 | 2020 | 39 | 0.690 |
Why?
| Virtual Reality | 1 | 2020 | 38 | 0.690 |
Why?
| Internship and Residency | 2 | 2021 | 926 | 0.690 |
Why?
| Neurodegenerative Diseases | 1 | 2021 | 93 | 0.670 |
Why?
| Inservice Training | 2 | 2017 | 105 | 0.660 |
Why?
| Hospitalization | 5 | 2023 | 1752 | 0.650 |
Why?
| Ambulatory Care Facilities | 2 | 2019 | 213 | 0.640 |
Why?
| Sports | 1 | 2021 | 187 | 0.640 |
Why?
| Antibodies, Monoclonal | 8 | 2021 | 1264 | 0.640 |
Why?
| Activities of Daily Living | 1 | 2022 | 349 | 0.640 |
Why?
| Pharmacists | 1 | 2021 | 234 | 0.640 |
Why?
| CD40 Antigens | 4 | 2006 | 82 | 0.620 |
Why?
| Independent Living | 2 | 2018 | 84 | 0.610 |
Why?
| Stakeholder Participation | 1 | 2019 | 73 | 0.610 |
Why?
| Attitude of Health Personnel | 5 | 2022 | 975 | 0.590 |
Why?
| Alzheimer Disease | 1 | 2023 | 442 | 0.580 |
Why?
| Betacoronavirus | 1 | 2020 | 250 | 0.570 |
Why?
| Resuscitation Orders | 3 | 2023 | 45 | 0.560 |
Why?
| Outpatients | 1 | 2020 | 326 | 0.550 |
Why?
| Perception | 2 | 2020 | 310 | 0.550 |
Why?
| Clinical Protocols | 1 | 2018 | 233 | 0.550 |
Why?
| Nurse Practitioners | 1 | 2018 | 102 | 0.540 |
Why?
| Physicians, Primary Care | 1 | 2019 | 223 | 0.540 |
Why?
| Social Media | 1 | 2019 | 131 | 0.540 |
Why?
| Geriatric Assessment | 1 | 2018 | 176 | 0.540 |
Why?
| Marijuana Use | 4 | 2020 | 167 | 0.530 |
Why?
| Patient Education as Topic | 5 | 2019 | 680 | 0.520 |
Why?
| Health Services Accessibility | 2 | 2021 | 763 | 0.510 |
Why?
| Middle Aged | 16 | 2025 | 26740 | 0.500 |
Why?
| Pneumonia, Viral | 1 | 2020 | 338 | 0.490 |
Why?
| Coronavirus Infections | 1 | 2020 | 330 | 0.490 |
Why?
| Policy | 1 | 2016 | 137 | 0.490 |
Why?
| Cardiotonic Agents | 1 | 2015 | 119 | 0.480 |
Why?
| Drug Utilization | 1 | 2015 | 167 | 0.470 |
Why?
| Interviews as Topic | 3 | 2023 | 584 | 0.470 |
Why?
| Life Change Events | 1 | 2015 | 135 | 0.460 |
Why?
| Patient Readmission | 4 | 2021 | 610 | 0.450 |
Why?
| Education, Medical | 1 | 2017 | 215 | 0.450 |
Why?
| Decision Making | 4 | 2017 | 782 | 0.450 |
Why?
| Patient Care Planning | 3 | 2020 | 139 | 0.450 |
Why?
| Physician's Role | 1 | 2015 | 197 | 0.440 |
Why?
| Patient Discharge | 4 | 2021 | 772 | 0.430 |
Why?
| Nurses | 1 | 2015 | 145 | 0.420 |
Why?
| Quality Assurance, Health Care | 1 | 2015 | 311 | 0.420 |
Why?
| Emergency Service, Hospital | 1 | 2023 | 1820 | 0.400 |
Why?
| Quality of Life | 3 | 2023 | 2353 | 0.400 |
Why?
| Canada | 5 | 2023 | 322 | 0.380 |
Why?
| Depression | 3 | 2018 | 1135 | 0.380 |
Why?
| Brain Neoplasms | 1 | 2019 | 979 | 0.380 |
Why?
| Interpersonal Relations | 1 | 2014 | 341 | 0.370 |
Why?
| Culture | 1 | 2012 | 124 | 0.370 |
Why?
| Melanoma, Experimental | 3 | 2006 | 89 | 0.370 |
Why?
| Emergency Medical Services | 1 | 2018 | 590 | 0.370 |
Why?
| Long-Term Care | 2 | 2021 | 78 | 0.360 |
Why?
| Health Status | 1 | 2016 | 722 | 0.360 |
Why?
| Nursing Homes | 3 | 2023 | 138 | 0.360 |
Why?
| Patients | 1 | 2012 | 163 | 0.360 |
Why?
| Health Information Exchange | 2 | 2021 | 12 | 0.350 |
Why?
| Geriatrics | 2 | 2021 | 69 | 0.340 |
Why?
| Electronic Mail | 2 | 2019 | 54 | 0.320 |
Why?
| Cross-Sectional Studies | 4 | 2023 | 4411 | 0.320 |
Why?
| Influenza, Human | 1 | 2014 | 545 | 0.310 |
Why?
| Retrospective Studies | 6 | 2023 | 12558 | 0.300 |
Why?
| Peer Group | 2 | 2020 | 201 | 0.300 |
Why?
| Adult | 10 | 2023 | 30562 | 0.300 |
Why?
| Health Communication | 2 | 2019 | 40 | 0.300 |
Why?
| Hospital Mortality | 1 | 2012 | 776 | 0.300 |
Why?
| Neuroblastoma | 2 | 2006 | 133 | 0.300 |
Why?
| Clinical Decision-Making | 2 | 2022 | 268 | 0.290 |
Why?
| Organizations, Nonprofit | 1 | 2007 | 17 | 0.280 |
Why?
| Colorado | 8 | 2023 | 4100 | 0.270 |
Why?
| United States | 9 | 2023 | 12184 | 0.270 |
Why?
| Health Resources | 1 | 2007 | 122 | 0.260 |
Why?
| Immunotherapy | 2 | 2008 | 474 | 0.260 |
Why?
| Automobile Driving | 2 | 2019 | 128 | 0.250 |
Why?
| Anti-Retroviral Agents | 1 | 2007 | 207 | 0.240 |
Why?
| Immunization, Passive | 1 | 2005 | 73 | 0.240 |
Why?
| Multimorbidity | 1 | 2025 | 33 | 0.240 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 1728 | 0.240 |
Why?
| Telerehabilitation | 1 | 2025 | 29 | 0.230 |
Why?
| Antibodies, Bispecific | 1 | 2005 | 32 | 0.230 |
Why?
| Healthcare Disparities | 2 | 2021 | 480 | 0.230 |
Why?
| Internet | 2 | 2018 | 596 | 0.230 |
Why?
| T-Lymphocytes | 4 | 2006 | 1737 | 0.230 |
Why?
| Social Work | 2 | 2022 | 74 | 0.220 |
Why?
| Pilot Projects | 4 | 2022 | 1373 | 0.220 |
Why?
| Sleep Aids, Pharmaceutical | 1 | 2022 | 2 | 0.210 |
Why?
| Telemedicine | 2 | 2021 | 662 | 0.210 |
Why?
| Referral and Consultation | 2 | 2018 | 635 | 0.200 |
Why?
| Macrophages | 2 | 2006 | 1263 | 0.200 |
Why?
| Interleukin-2 | 3 | 2009 | 413 | 0.200 |
Why?
| Death | 1 | 2022 | 107 | 0.190 |
Why?
| HIV-1 | 1 | 2007 | 768 | 0.190 |
Why?
| Potentially Inappropriate Medication List | 1 | 2021 | 14 | 0.190 |
Why?
| Perioperative Care | 1 | 2022 | 127 | 0.190 |
Why?
| Macrophages, Peritoneal | 3 | 2006 | 93 | 0.190 |
Why?
| Comorbidity | 2 | 2016 | 1448 | 0.190 |
Why?
| Digital Divide | 1 | 2021 | 3 | 0.190 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1140 | 0.180 |
Why?
| Nitric Oxide | 1 | 2006 | 823 | 0.180 |
Why?
| Deprescriptions | 1 | 2021 | 27 | 0.180 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 119 | 0.180 |
Why?
| Personhood | 1 | 2020 | 3 | 0.180 |
Why?
| Receptors, GABA-A | 1 | 2021 | 82 | 0.180 |
Why?
| Macrophage Activation | 3 | 2006 | 164 | 0.180 |
Why?
| Geriatric Psychiatry | 1 | 2020 | 11 | 0.180 |
Why?
| Program Evaluation | 1 | 2025 | 822 | 0.180 |
Why?
| Mass Screening | 1 | 2007 | 1006 | 0.180 |
Why?
| Multiple Chronic Conditions | 1 | 2020 | 24 | 0.170 |
Why?
| Veterans | 2 | 2025 | 1249 | 0.170 |
Why?
| Health Expenditures | 1 | 2021 | 171 | 0.170 |
Why?
| Organization and Administration | 1 | 2019 | 8 | 0.170 |
Why?
| Delphi Technique | 2 | 2017 | 160 | 0.170 |
Why?
| Patient Preference | 2 | 2022 | 167 | 0.170 |
Why?
| Europe | 1 | 2020 | 334 | 0.160 |
Why?
| Inpatients | 1 | 2023 | 380 | 0.160 |
Why?
| Prognosis | 2 | 2018 | 3330 | 0.160 |
Why?
| Health Plan Implementation | 1 | 2020 | 132 | 0.160 |
Why?
| Reimbursement Mechanisms | 1 | 2019 | 77 | 0.160 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1394 | 0.160 |
Why?
| Software Design | 1 | 2018 | 24 | 0.160 |
Why?
| Patient Navigation | 1 | 2020 | 64 | 0.160 |
Why?
| Medical Futility | 1 | 2018 | 20 | 0.160 |
Why?
| Community-Institutional Relations | 1 | 2019 | 89 | 0.160 |
Why?
| Neoplasms | 2 | 2022 | 2097 | 0.150 |
Why?
| Recreation | 1 | 2018 | 21 | 0.150 |
Why?
| Needs Assessment | 1 | 2020 | 315 | 0.150 |
Why?
| Mentoring | 1 | 2020 | 100 | 0.150 |
Why?
| Rural Population | 1 | 2022 | 446 | 0.150 |
Why?
| Delivery of Health Care, Integrated | 1 | 2021 | 228 | 0.150 |
Why?
| Developed Countries | 1 | 2018 | 28 | 0.150 |
Why?
| Cytotoxicity, Immunologic | 4 | 2006 | 195 | 0.150 |
Why?
| Decision Making, Computer-Assisted | 1 | 2018 | 18 | 0.150 |
Why?
| Prostatic Neoplasms | 1 | 2005 | 921 | 0.150 |
Why?
| Longitudinal Studies | 2 | 2016 | 2387 | 0.150 |
Why?
| Ecosystem | 1 | 2022 | 502 | 0.140 |
Why?
| Research Personnel | 1 | 2019 | 149 | 0.140 |
Why?
| Video Recording | 1 | 2018 | 143 | 0.140 |
Why?
| Quality of Health Care | 1 | 2022 | 573 | 0.140 |
Why?
| Reading | 1 | 2018 | 149 | 0.140 |
Why?
| Academic Medical Centers | 1 | 2019 | 411 | 0.140 |
Why?
| Program Development | 1 | 2019 | 341 | 0.140 |
Why?
| Universities | 1 | 2019 | 341 | 0.140 |
Why?
| Cannabis | 2 | 2020 | 384 | 0.140 |
Why?
| Brain Ischemia | 1 | 2020 | 299 | 0.140 |
Why?
| Health Services Research | 1 | 2019 | 371 | 0.130 |
Why?
| Pain Management | 1 | 2019 | 288 | 0.130 |
Why?
| Young Adult | 3 | 2021 | 10472 | 0.130 |
Why?
| Community Health Services | 1 | 2018 | 212 | 0.130 |
Why?
| Neoplasms, Experimental | 2 | 2008 | 151 | 0.130 |
Why?
| Hypesthesia | 1 | 2016 | 16 | 0.130 |
Why?
| Disease Management | 2 | 2019 | 560 | 0.130 |
Why?
| Housing for the Elderly | 1 | 2015 | 7 | 0.130 |
Why?
| Chest Pain | 1 | 2016 | 81 | 0.130 |
Why?
| Workflow | 1 | 2016 | 133 | 0.130 |
Why?
| Terminology as Topic | 1 | 2017 | 187 | 0.130 |
Why?
| Financing, Personal | 1 | 2015 | 25 | 0.120 |
Why?
| Evidence-Based Medicine | 1 | 2019 | 668 | 0.120 |
Why?
| Firearms | 1 | 2020 | 300 | 0.120 |
Why?
| Curriculum | 1 | 2021 | 819 | 0.120 |
Why?
| Professional Role | 1 | 2016 | 149 | 0.120 |
Why?
| Cell Line, Tumor | 6 | 2009 | 2711 | 0.120 |
Why?
| Environment | 1 | 2016 | 332 | 0.120 |
Why?
| Residence Characteristics | 1 | 2016 | 275 | 0.120 |
Why?
| Family Practice | 1 | 2018 | 427 | 0.110 |
Why?
| Cytokines | 4 | 2006 | 1841 | 0.110 |
Why?
| Communication Barriers | 1 | 2014 | 89 | 0.110 |
Why?
| Patient Reported Outcome Measures | 1 | 2016 | 250 | 0.110 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 916 | 0.110 |
Why?
| Motivational Interviewing | 1 | 2015 | 88 | 0.110 |
Why?
| HIV Infections | 1 | 2007 | 2469 | 0.110 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 681 | 0.100 |
Why?
| State Medicine | 1 | 2012 | 18 | 0.100 |
Why?
| Multivariate Analysis | 1 | 2016 | 1430 | 0.100 |
Why?
| Stroke | 1 | 2020 | 1022 | 0.100 |
Why?
| Attitude to Health | 1 | 2015 | 406 | 0.090 |
Why?
| Benzodiazepines | 2 | 2022 | 116 | 0.090 |
Why?
| Severity of Illness Index | 1 | 2018 | 2540 | 0.090 |
Why?
| Chronic Disease | 1 | 2017 | 1579 | 0.090 |
Why?
| Respiratory Mechanics | 1 | 1990 | 56 | 0.090 |
Why?
| Goals | 2 | 2022 | 147 | 0.080 |
Why?
| Prevalence | 1 | 2016 | 2251 | 0.080 |
Why?
| Risk Factors | 3 | 2023 | 8634 | 0.080 |
Why?
| Prospective Studies | 2 | 2019 | 6220 | 0.080 |
Why?
| Adolescent | 3 | 2021 | 17856 | 0.080 |
Why?
| Killer Cells, Natural | 3 | 2006 | 380 | 0.080 |
Why?
| Mice, Inbred C57BL | 3 | 2006 | 4694 | 0.080 |
Why?
| Mice, SCID | 2 | 2006 | 314 | 0.080 |
Why?
| Treatment Outcome | 2 | 2020 | 9089 | 0.080 |
Why?
| Mice | 8 | 2009 | 14872 | 0.080 |
Why?
| Recombinant Fusion Proteins | 2 | 2008 | 616 | 0.070 |
Why?
| Feasibility Studies | 2 | 2022 | 737 | 0.070 |
Why?
| Nigeria | 1 | 2007 | 14 | 0.070 |
Why?
| Pulmonary Alveoli | 1 | 1990 | 373 | 0.070 |
Why?
| Colonic Neoplasms | 1 | 2009 | 215 | 0.070 |
Why?
| Immunologic Memory | 1 | 2009 | 313 | 0.070 |
Why?
| Hospitals | 2 | 2022 | 581 | 0.070 |
Why?
| Religion | 1 | 2007 | 64 | 0.070 |
Why?
| Stress, Psychological | 1 | 2014 | 944 | 0.070 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 38 | 0.070 |
Why?
| Mice, Inbred A | 1 | 2006 | 45 | 0.070 |
Why?
| Subcutaneous Tissue | 1 | 2006 | 17 | 0.070 |
Why?
| Vaccination | 1 | 2014 | 1204 | 0.070 |
Why?
| Toll-Like Receptor 9 | 1 | 2006 | 30 | 0.060 |
Why?
| Neoplasm Transplantation | 1 | 2006 | 228 | 0.060 |
Why?
| Mice, Mutant Strains | 1 | 2006 | 271 | 0.060 |
Why?
| Self Report | 2 | 2019 | 696 | 0.060 |
Why?
| Nitric Oxide Synthase | 1 | 2006 | 209 | 0.060 |
Why?
| Antigen Presentation | 1 | 2006 | 188 | 0.060 |
Why?
| CD3 Complex | 1 | 2005 | 92 | 0.060 |
Why?
| Animals | 10 | 2009 | 31710 | 0.060 |
Why?
| Tumor Cells, Cultured | 1 | 2006 | 850 | 0.060 |
Why?
| Lymphocyte Activation | 2 | 2006 | 1037 | 0.060 |
Why?
| Immunoconjugates | 1 | 2005 | 87 | 0.060 |
Why?
| Terminally Ill | 1 | 2023 | 33 | 0.050 |
Why?
| Morals | 1 | 2023 | 65 | 0.050 |
Why?
| Adenocarcinoma | 1 | 2009 | 795 | 0.050 |
Why?
| Disclosure | 1 | 2023 | 101 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 2894 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2006 | 750 | 0.050 |
Why?
| Lipopolysaccharides | 1 | 2006 | 823 | 0.050 |
Why?
| Receptor, ErbB-2 | 1 | 2005 | 300 | 0.050 |
Why?
| Pregnancy Proteins | 1 | 2002 | 36 | 0.050 |
Why?
| Cohort Studies | 1 | 2012 | 4895 | 0.050 |
Why?
| Patient Care | 1 | 2023 | 101 | 0.050 |
Why?
| Interferon-gamma | 1 | 2005 | 719 | 0.050 |
Why?
| Asia | 1 | 2021 | 53 | 0.050 |
Why?
| Neutrophils | 1 | 2006 | 1176 | 0.040 |
Why?
| Pharmaceutical Preparations | 1 | 2022 | 165 | 0.040 |
Why?
| Thrombectomy | 1 | 2020 | 51 | 0.040 |
Why?
| Ownership | 1 | 2020 | 81 | 0.040 |
Why?
| Senior Centers | 1 | 2019 | 1 | 0.040 |
Why?
| Mortality | 1 | 2021 | 287 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2020 | 257 | 0.040 |
Why?
| Interprofessional Relations | 1 | 2021 | 249 | 0.040 |
Why?
| Confidentiality | 1 | 2019 | 67 | 0.040 |
Why?
| Vulnerable Populations | 1 | 2020 | 134 | 0.040 |
Why?
| Safety | 1 | 2020 | 298 | 0.040 |
Why?
| Informed Consent | 1 | 2019 | 161 | 0.040 |
Why?
| Professional-Patient Relations | 1 | 2019 | 141 | 0.040 |
Why?
| Minority Health | 1 | 2018 | 19 | 0.040 |
Why?
| Rats | 1 | 2006 | 4959 | 0.040 |
Why?
| Social Values | 1 | 2018 | 36 | 0.040 |
Why?
| California | 1 | 2018 | 353 | 0.030 |
Why?
| Interdisciplinary Research | 1 | 2017 | 25 | 0.030 |
Why?
| Students | 1 | 2021 | 502 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2020 | 1079 | 0.030 |
Why?
| Patient Safety | 1 | 2019 | 277 | 0.030 |
Why?
| Internationality | 1 | 2017 | 143 | 0.030 |
Why?
| Racism | 1 | 2018 | 102 | 0.030 |
Why?
| Time Factors | 3 | 2020 | 6114 | 0.030 |
Why?
| Personal Autonomy | 1 | 2015 | 39 | 0.030 |
Why?
| Delivery of Health Care | 1 | 2020 | 833 | 0.030 |
Why?
| Flow Cytometry | 2 | 2008 | 1083 | 0.030 |
Why?
| Empathy | 1 | 2015 | 139 | 0.030 |
Why?
| Pain | 1 | 2018 | 705 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2020 | 2766 | 0.030 |
Why?
| Anxiety | 1 | 2018 | 840 | 0.020 |
Why?
| Spleen | 2 | 2004 | 487 | 0.020 |
Why?
| Lung Volume Measurements | 1 | 1990 | 45 | 0.020 |
Why?
| Gerbillinae | 1 | 1990 | 61 | 0.020 |
Why?
| Cell Membrane Permeability | 1 | 1989 | 83 | 0.020 |
Why?
| Pressure | 1 | 1990 | 214 | 0.020 |
Why?
| Albumins | 1 | 1989 | 89 | 0.020 |
Why?
| Thrombin | 1 | 1989 | 139 | 0.020 |
Why?
| Child | 1 | 2007 | 18423 | 0.020 |
Why?
| Peptides, Cyclic | 1 | 1989 | 253 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2009 | 1144 | 0.020 |
Why?
| Apoptosis | 2 | 2006 | 2363 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2009 | 1121 | 0.020 |
Why?
| Catheter Ablation | 1 | 2009 | 288 | 0.020 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2008 | 699 | 0.020 |
Why?
| Cell Division | 2 | 2002 | 758 | 0.020 |
Why?
| CpG Islands | 1 | 2006 | 118 | 0.020 |
Why?
| Leukemia L5178 | 1 | 2005 | 1 | 0.020 |
Why?
| Jurkat Cells | 1 | 2005 | 128 | 0.020 |
Why?
| Immunophenotyping | 1 | 2006 | 274 | 0.010 |
Why?
| Mice, Inbred C3H | 1 | 2005 | 239 | 0.010 |
Why?
| Coculture Techniques | 1 | 2005 | 201 | 0.010 |
Why?
| Liver Neoplasms, Experimental | 1 | 2004 | 26 | 0.010 |
Why?
| Gangliosides | 1 | 2004 | 18 | 0.010 |
Why?
| Cytoplasm | 1 | 2005 | 255 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 2004 | 396 | 0.010 |
Why?
| Ligands | 1 | 2005 | 562 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1989 | 847 | 0.010 |
Why?
| Megakaryocytes | 1 | 2002 | 30 | 0.010 |
Why?
| CHO Cells | 1 | 2002 | 138 | 0.010 |
Why?
| Cricetinae | 1 | 2002 | 253 | 0.010 |
Why?
| Neoplasm Metastasis | 1 | 2004 | 523 | 0.010 |
Why?
| Bone Marrow Cells | 1 | 2002 | 267 | 0.010 |
Why?
| Gestational Age | 1 | 2002 | 760 | 0.010 |
Why?
| Hematopoietic Stem Cells | 1 | 2002 | 343 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2002 | 1230 | 0.010 |
Why?
| Mice, Knockout | 1 | 2005 | 2570 | 0.010 |
Why?
| Fetus | 1 | 2002 | 700 | 0.010 |
Why?
| Cell Differentiation | 1 | 2002 | 1701 | 0.010 |
Why?
| Cells, Cultured | 1 | 2002 | 3886 | 0.010 |
Why?
| Pregnancy | 1 | 2002 | 5520 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1989 | 396 | 0.000 |
Why?
| Actins | 1 | 1989 | 381 | 0.000 |
Why?
| Cattle | 1 | 1989 | 920 | 0.000 |
Why?
| Cell Survival | 1 | 1989 | 1021 | 0.000 |
Why?
| Cell Membrane | 1 | 1989 | 680 | 0.000 |
Why?
|
|
Lum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|